Prof. Dr. Wolfgang Hoffmann, MPH
Speaker and Group Leader
Prof. Hoffmann is head of the Dept. Versorgungsepidemiologie und Community Health of the Institute fur Community Medicine at the Universitätsmedizin Greifswald
German Center for Neurodegenerative Diseases (DZNE)
c/o Institute for Community Medicine
Dept. Versorgnungsepidemiologie und Community Health
+49 (0) 3834 / 867751
+49 (0) 3834 / 867752
|Christiane Schnick, Secretary||+49 (0) 3834 / 86-7593|
|Ulrike Borchardt, Research Associate||+49 (0) 3834 / 86-6918|
|Dr. Tilly Eichler, Research Associate||+49 (0) 3834 / 86-7591|
|Pia Erdmann, Research Associate||+49 (0) 3834 / 86-7507|
|Leonore Köhler, Research Associate||+49 (0) 3834 / 86-7506|
|Dr. René Thyrian, Research Associate||+49 (0) 3834 / 86-7592|
|Katharina Wittfeld, Research Associate||+49 (0) 3834 / 86-6920|
|Diana Wucherer, Research Associate||+49 (0) 3834 / 86-7776|
|Markus Wübbeler, M. Sc., Healthcare and Nurse Scientist||+49 (0) 3834 / 86-7506|
|Kerstin Albuerne, Medical Documentalist||+49 (0) 3834 / 86-19552|
|Christine Winckler, Study Nurse||+49 (0) 3834 / 86-7593|
Prof. Dr. med. Wolfgang Hoffmann, MPH was born in 1963 in Cologne. After completion of his medical studies at the Universities of Bonn and Göttingen in 1991, he worked as postdoctoral fellow at the Bremen Institute for Prevention Research and Social Medicine, Germany from 1992-2002. In 1993 he obtained his medical approbation and having defended his dissertation obtained his Dr. med from the University of Marburg, Germany in the same year. In 1995 he qualified for “Master of Public Health (MHP) in Epidemiology” at the Department of Epidemiology, University of North Carolina at Chapel Hill, United States of America.
In 2002 Prof. Dr. med. Wolfgang Hoffmann was offered a BMBF-sponsored professorship and two years later a full professorship for Epidemiology of Health Care and Community Health at the Medical School of the Ernst-Moritz-Arndt-University Greifswald, Germany.
Since 2007 he has been Acting Director of the Institute for Community Medicine.
Professor Hoffman has been long standing member of the German Society for Epidemiology (DGEpi) for which he served as President from 2008-2009.
Since 2009 he has been member and one of the four speakers of the epidemiological planning committee (EPC) of the National Cohort. In 2008 he became member of the board of the Technology, Methods, and Infrastructure for Networked Medical Research (TMF e.V.) of the BMBF. Also 2008 he became appointed member of the “Advisory Board on Health Reporting in Germany” at the Robert-Koch Institute Berlin.
In 2011 he was offered a professorship for population based Epidemiology of Health Care and Community Health at the University Medicine Greifswald, Germany. In September of the same year Professor Hoffman became appointed member of the Steering Committee “Innovations in Medical Technology” of the Federal Government of Germany, operated by BMBF, BMG and BMWi. Since January 2013 he is speaker and groupleader of the DZNE Rostock / Greifswald.
Areas of investigation/research focus
In Greifswald, Prof. W. Hoffmann is the head of 5 scientists (3,5 full time equivalents), 1 doctoral student, 7 non-scientific employees working for the DZNE. In cooperation with the university, Greifswald has established 4 working groups interventional health care epidemiology (PD Dr. JR Thyrian), care management and qualification (A. Dreier), health economics (Prof. S. Fleßa) and psychiatric health care (Prof. HJ. Grabe). These working groups define the project areas and the university medicine is cooperating in and providing manpower to these. The main project area in Greifswald is population-based interventional dementia research, in which all working groups are involved.
Background: The DZNE Rostock/Greifswald represents the final stage of the translational research of the DZNE from basic science models across transgenic animals, through clinical patient-based studies to primary care/ population intervention. Research areas are defined by already existing problems as well as mid- and longterm expected needs.
(i) Health care for patients with dementia living at home and their caregivers is insufficient. A curative pharmacotherapy and non-pharmacological treatment is lacking. Existing treatment guidelines are inconsistent and incompatible, their practice impact limited. Research is needed that improves health care, diagnosis and treatment in the population. Special emphasis needs to be put on the translation of clinical standards into the health care system.
(ii) The care structure and the provision of care show a discrepancy between needs and structure. There is limited access and availability, barriers in utilization, interface problems between different care sectors, a lack of knowledge and qualification. The caregiver is systematically not a target of the health care system. Research is needed to develop concepts and evaluate their implementation in the real world structure (i.e. integrated care). Special emphasis must be put on clinical effectiveness and health economic efficiency. Furthermore, the caregiver needs to be a focus of attention; evidence-based qualification for professional helpers is needed.
(iii) There is few research in delivery of dementia care and limited exchange between researchers in the field. Furthermore the exchange between researchers and people working in the field/ stakeholders is limited. In the future, research priorities will be defined in exchange between researchers and people in the field/stakeholders. This will support improvement of health policy on a regional, national and international level.
The overall aim is to develop and support implementation of evidence-based, sustainable and cost-effective support pathways for the health and well-being of people with dementia and their families in the primary care system and their integration in legislation and guidelines for medical and nursing care.